Volver a Agenda
Session Chair(s)
Kimberly Westrich, MA
Director, Health Services Research
National Pharmaceutical Council, United States
Learning Objective : Describe stakeholder views on the impact of comparative effectiveness research (CER) for health care decision-making; Discuss how payers consider and use CER to make decisions; Define models for collection of real-world, observational data directly through patients.
Speaker(s)
Monitoring Changes in the Environment for Health Care Decision-making
Kimberly Westrich, MA
National Pharmaceutical Council, United States
Director, Health Services Research
Translating CER into Medical Payment Policy: Views from Public and Private Payers
Joel S. Weissman, PHD
Harvard Medical School, United States
Associate Professor, Health Policy
Working Directly with Patients to Collect HEO/CER Data Using Innovative Hybrid Observational Research Models
John Reites
THREAD, United States
Chief Executive Officer
¿Tiene una cuenta?